Sarah Mary Carlton Colbert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sarah Mary Carlton Colbert has a total of 249 co-authors. Here are the top co-authors by number of shared publications:
- Emma C. Johnson
Department of Psychiatry Washington University School of Medicine St. Louis Missouri USA
16 shared publications - Alexander S. Hatoum
Washington University School of Medicine
10 shared publications Arpana Agrawal
Department of Psychiatry, Washington University School of Medicine
9 shared publications- Anna R. Docherty
Department of Psychiatry & Huntsman Mental Health Institute, University of Utah School of Medicine, Salt Lake City, USA
8 shared publications - Hilary Coon
University of Utah
7 shared publications - Howard J. Edenberg
Indiana University School of Medicine
7 shared publications
Latest Publications
- Open Access
- 2 June 2026
- Published by Springer Nature in Research Square
Investigating genetic overlap of multidimensional pain and suicidal behaviors in >2 million individuals
Although chronic pain is a major risk factor for suicidal behaviors, the shared genetic underpinnings of these phenotypes are poorly understood. This study leveraged genome-wide association data to examine the shared genetic architecture between multidimensional pain (MP), capturing broad genetic liability to chronic pain ( n = 1,235,695), and suicidal behaviors, including suicide attempt (SA, n = 787,974) and suicide death (SD, n = 18,223). Integrative cross-trait genetic analyses revealed substantial polygenic overlap between MP and both suicidal behaviors, and identified 76 (244 genes) and 10 (27 genes) distinct shared loci for SA and SD, respectively. The genes mapped to the shared SA loci were enriched in neuronal and synaptic pathways, and integration of multi-omics data further prioritized 10 genes, providing convergent molecular context relevant to the neurobiological and behavioral pathways implicated in the association between pain liability and SA. Mendelian randomization analyses supported a potential causal relationship between MP and both suicidal behaviors, with asymmetric bidirectional effects for MP and SA. Mediation analyses further indicated that 14 health-related traits, including psychological and substance-related behaviors, partially mediated the association between MP and SA. Together, these findings reveal shared genetic architecture between MP and suicidal behaviors, with the association partially mediated by convergent neurobiological and potentially modifiable behavioral pathways relevant to prevention and therapeutic efforts.
- 2 June 2026
- Published by Springer Nature in Research Square
Open AccessInvestigating genetic overlap of multidimensional pain and suicidal behaviors in >2 million individuals
Although chronic pain is a major risk factor for suicidal behaviors, the shared genetic underpinnings of these phenotypes are poorly understood. This study leveraged genome-wide association data to examine the shared genetic architecture between multidimensional pain (MP), capturing broad genetic liability to chronic pain ( n = 1,235,695), and suicidal behaviors, including suicide attempt (SA, n = 787,974) and suicide death (SD, n = 18,223). Integrative cross-trait genetic analyses revealed substantial polygenic overlap between MP and both suicidal behaviors, and identified 76 (244 genes) and 10 (27 genes) distinct shared loci for SA and SD, respectively. The genes mapped to the shared SA loci were enriched in neuronal and synaptic pathways, and integration of multi-omics data further prioritized 10 genes, providing convergent molecular context relevant to the neurobiological and behavioral pathways implicated in the association between pain liability and SA. Mendelian randomization analyses supported a potential causal relationship between MP and both suicidal behaviors, with asymmetric bidirectional effects for MP and SA. Mediation analyses further indicated that 14 health-related traits, including psychological and substance-related behaviors, partially mediated the association between MP and SA. Together, these findings reveal shared genetic architecture between MP and suicidal behaviors, with the association partially mediated by convergent neurobiological and potentially modifiable behavioral pathways relevant to prevention and therapeutic efforts.
- Open Access
Suicidality phenotypes reflect both shared and distinct genetic factors
Suicidality phenotypes, including suicidal ideation (SI), non-fatal suicide attempt (SA), and suicide death (SD), are heritable and exhibit both shared and phenotype-specific genetic influences. Using genomic structural equation modelling, we estimated the shared genetic architecture across GWAS of SI (176,147 cases, 1,010,300 controls), SA (53,919 cases, 1,063,988 controls), and SD (7,584 cases, 652,070 controls) and conducted a multivariate GWAS of a latent suicidality factor capturing their shared liability. This analysis identified 36 genome-wide significant loci, including seven not previously reported in any suicidality GWAS. Follow-up analyses identified residual genetic variance specific to each phenotype, including three SD-specific genomic risk loci. Conditioning suicidality phenotypes on genetic liability to psychiatric disorders revealed significant residual genetic variance across SI, SA, SD, and the suicidality common factor. Together, these results suggest that suicidality reflects both shared genetic liability and phenotype-specific contributions.
Open AccessSuicidality phenotypes reflect both shared and distinct genetic factors
Suicidality phenotypes, including suicidal ideation (SI), non-fatal suicide attempt (SA), and suicide death (SD), are heritable and exhibit both shared and phenotype-specific genetic influences. Using genomic structural equation modelling, we estimated the shared genetic architecture across GWAS of SI (176,147 cases, 1,010,300 controls), SA (53,919 cases, 1,063,988 controls), and SD (7,584 cases, 652,070 controls) and conducted a multivariate GWAS of a latent suicidality factor capturing their shared liability. This analysis identified 36 genome-wide significant loci, including seven not previously reported in any suicidality GWAS. Follow-up analyses identified residual genetic variance specific to each phenotype, including three SD-specific genomic risk loci. Conditioning suicidality phenotypes on genetic liability to psychiatric disorders revealed significant residual genetic variance across SI, SA, SD, and the suicidality common factor. Together, these results suggest that suicidality reflects both shared genetic liability and phenotype-specific contributions.
- Open Access
Genome-wide association studies identify 77 loci for suicidality and provide novel biological insights
Suicidality contributes substantially to global morbidity and mortality, yet despite its heritability, its biological etiology remains largely elusive. We conducted multi-ancestry genome-wide association study meta-analyses of suicidal ideation (259,747 cases), suicide attempt (64,993 cases), suicide death (9,197 cases), and suicidal behavior (suicide attempt/ death, 75,300 cases), across 54 cohorts (e.g., the Psychiatric Genomics Consortium, Million Veteran Program, UK Biobank). We identified 77 significant loci across meta-analyses, including 59 previously unreported for suicidality. SNP-based heritability ranged from 2.0-6.7% and there were strong, yet incomplete, genetic correlations between suicidality phenotypes (0.70-0.88). Fine-mapping prioritized putative causal SNPs and 20 credible genes. Enrichment analyses implicated synaptic pathways and neuronal populations predominantly in subcortical brain regions (e.g., amygdala excitatory, medium spiny, hippocampal CA1-3). Together, these findings establish suicidality as a polygenic set of traits with both shared and distinct genetic influences, providing a foundation for future studies of suicide biology and etiology.
Open AccessGenome-wide association studies identify 77 loci for suicidality and provide novel biological insights
Suicidality contributes substantially to global morbidity and mortality, yet despite its heritability, its biological etiology remains largely elusive. We conducted multi-ancestry genome-wide association study meta-analyses of suicidal ideation (259,747 cases), suicide attempt (64,993 cases), suicide death (9,197 cases), and suicidal behavior (suicide attempt/ death, 75,300 cases), across 54 cohorts (e.g., the Psychiatric Genomics Consortium, Million Veteran Program, UK Biobank). We identified 77 significant loci across meta-analyses, including 59 previously unreported for suicidality. SNP-based heritability ranged from 2.0-6.7% and there were strong, yet incomplete, genetic correlations between suicidality phenotypes (0.70-0.88). Fine-mapping prioritized putative causal SNPs and 20 credible genes. Enrichment analyses implicated synaptic pathways and neuronal populations predominantly in subcortical brain regions (e.g., amygdala excitatory, medium spiny, hippocampal CA1-3). Together, these findings establish suicidality as a polygenic set of traits with both shared and distinct genetic influences, providing a foundation for future studies of suicide biology and etiology.
- Open Access
- 2 October 2025
- Published by Elsevier in Psychiatry Research
- Vol. 353, 116760
Defining and assessing international classification of disease suicidality phenotypes for genetic studies
- 2 October 2025
- Published by Elsevier in Psychiatry Research
- Vol. 353, 116760
Open AccessDefining and assessing international classification of disease suicidality phenotypes for genetic studies
- Open Access
- 25 September 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (12) , 6144-6154
Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group
Suicidality phenotypes, consisting of suicidal ideation (SI), suicide attempt (SA), and suicide death (SD), are all heritable but present unique challenges in genome-wide association studies (GWAS) due to their individual complexity, overlap with each other and with related self-harm phenotypes, and varying associations with psychiatric disorders. GWAS have uncovered several loci associated with suicidality phenotypes by meta-analyzing data from multiple cohorts. However, combining datasets from many research groups, where each group may use different study designs, phenotyping instruments, and definitions of suicidality phenotypes, presents challenges. Heterogeneity resulting from these differences can limit genetic discovery; harmonizing phenotype definitions to ensure consistency will greatly improve results. Here, we describe a standardized phenotyping protocol that draws on the expertise of a subgroup of clinicians, researchers, and experts from the Psychiatric Genomics Consortium Suicide Working Group to propose consensus definitions for SI, SA, and SD for genetic studies.
- 25 September 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (12) , 6144-6154
Open AccessDefining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group
Suicidality phenotypes, consisting of suicidal ideation (SI), suicide attempt (SA), and suicide death (SD), are all heritable but present unique challenges in genome-wide association studies (GWAS) due to their individual complexity, overlap with each other and with related self-harm phenotypes, and varying associations with psychiatric disorders. GWAS have uncovered several loci associated with suicidality phenotypes by meta-analyzing data from multiple cohorts. However, combining datasets from many research groups, where each group may use different study designs, phenotyping instruments, and definitions of suicidality phenotypes, presents challenges. Heterogeneity resulting from these differences can limit genetic discovery; harmonizing phenotype definitions to ensure consistency will greatly improve results. Here, we describe a standardized phenotyping protocol that draws on the expertise of a subgroup of clinicians, researchers, and experts from the Psychiatric Genomics Consortium Suicide Working Group to propose consensus definitions for SI, SA, and SD for genetic studies.
- Open Access
Different genetic liabilities to neuropsychiatric conditions in suicides with no prior suicidality
Importance.: Though suicide attempt is the most robust predictor of suicide death, few who attempt go on to die by suicide (<10%), and ∼50% of all suicide deaths occur in the absence of evidence of prior attempts. Risks in this latter group are particularly poorly understood. Objective.: Data from the Utah Suicide Mortality Risk Study (USMRS) were used to study underlying polygenic liabilities among suicide deaths without evidence of prior nonfatal suicidal thoughts or behaviors (SD-N) compared to suicide deaths with prior nonfatal suicidality (SD-S). Design.: We used an analysis of covariance design, comparing SD-N to SD-S and to population controls with similar genetic ancestry from the United Kingdom. Setting.: We selected 12 source studies to generate descriptive quantitative polygenic scores (PGS) reflecting neuropsychiatric conditions. Analysis of covariance was used to evaluate suicide mortality subsets and controls adjusted for sex, age, and genetic ancestry effects. Participants.: Suicide deaths were population-ascertained through a 25-year collaboration with the Utah State Office of the Medical Examiner. Evidence of suicidality was determined from diagnoses and clinical notes, yielding 1,364 SD-N and 1,467 SD-S deaths, compared to 20,368 controls. Main Outcomes.: The tested PGS spanned 12 psychiatric, neurodevelopmental, and neurodegenerative conditions. Results.: SD-N were significantly more male (82.33% vs. 67.76%) and older at death (47.26 years vs. 41.36 years) than SD-S. Controls were significantly less male than both suicide subsets (43.71%). Genetic ancestry was similar across suicide subsets and controls (% European: 96.77%, 96.81%, and 97.38%). Comparing SD-N to SD-S revealed significantly lower PGS in SD-N for: MDD (p=0.0015), neuroticism (p=0.0016), anxiety (p=0.0048), Alzheimer’s (p=0.011), depressed affect (p=0.015), schizophrenia (p=0.020), PTSD (p=0.023), and bipolar disorder (p=0.028). This attenuation in SD-N was particularly pronounced for depressed affect, neuroticism, and Alzheimer’s, where PGS were not different from controls. Sex-specific analyses suggested attenuation of PGS in SD-N was driven by males for MDD, anxiety, and PTSD, and by females for bipolar disorder, neuroticism, and Alzheimer’s. Conclusions and Relevance.: SD-N have significantly different genetic liabilities from SD-S, particularly regarding neuropsychiatric conditions. Results have far-reaching implications both for future research and for preventions for those at highest risk of mortality. KEY POINTS: Question: What are underlying genetic liabilities related to neuropsychiatric conditions in the roughly half of suicide deaths with no evidence of prior nonfatal suicidal thoughts or behaviors (SD-N), a group that has not previously been accessible for study? Findings: These suicide deaths with no prior nonfatal suicidality showed significantly attenuated underlying polygenic liabilities associated with mental health traditionally thought to be core features of suicide mortality risk, and justifies additional studies of underlying risks associated with non-psychiatric conditions and behaviors. Meaning: These differences in underlying liabilities between suicide deaths with and without prior suicidality suggest departure from the traditional mental health risks that have been the focus of suicide risk discovery, and impel new directions for future research and prevention efforts.
Open AccessDifferent genetic liabilities to neuropsychiatric conditions in suicides with no prior suicidality
Importance.: Though suicide attempt is the most robust predictor of suicide death, few who attempt go on to die by suicide (<10%), and ∼50% of all suicide deaths occur in the absence of evidence of prior attempts. Risks in this latter group are particularly poorly understood. Objective.: Data from the Utah Suicide Mortality Risk Study (USMRS) were used to study underlying polygenic liabilities among suicide deaths without evidence of prior nonfatal suicidal thoughts or behaviors (SD-N) compared to suicide deaths with prior nonfatal suicidality (SD-S). Design.: We used an analysis of covariance design, comparing SD-N to SD-S and to population controls with similar genetic ancestry from the United Kingdom. Setting.: We selected 12 source studies to generate descriptive quantitative polygenic scores (PGS) reflecting neuropsychiatric conditions. Analysis of covariance was used to evaluate suicide mortality subsets and controls adjusted for sex, age, and genetic ancestry effects. Participants.: Suicide deaths were population-ascertained through a 25-year collaboration with the Utah State Office of the Medical Examiner. Evidence of suicidality was determined from diagnoses and clinical notes, yielding 1,364 SD-N and 1,467 SD-S deaths, compared to 20,368 controls. Main Outcomes.: The tested PGS spanned 12 psychiatric, neurodevelopmental, and neurodegenerative conditions. Results.: SD-N were significantly more male (82.33% vs. 67.76%) and older at death (47.26 years vs. 41.36 years) than SD-S. Controls were significantly less male than both suicide subsets (43.71%). Genetic ancestry was similar across suicide subsets and controls (% European: 96.77%, 96.81%, and 97.38%). Comparing SD-N to SD-S revealed significantly lower PGS in SD-N for: MDD (p=0.0015), neuroticism (p=0.0016), anxiety (p=0.0048), Alzheimer’s (p=0.011), depressed affect (p=0.015), schizophrenia (p=0.020), PTSD (p=0.023), and bipolar disorder (p=0.028). This attenuation in SD-N was particularly pronounced for depressed affect, neuroticism, and Alzheimer’s, where PGS were not different from controls. Sex-specific analyses suggested attenuation of PGS in SD-N was driven by males for MDD, anxiety, and PTSD, and by females for bipolar disorder, neuroticism, and Alzheimer’s. Conclusions and Relevance.: SD-N have significantly different genetic liabilities from SD-S, particularly regarding neuropsychiatric conditions. Results have far-reaching implications both for future research and for preventions for those at highest risk of mortality. KEY POINTS: Question: What are underlying genetic liabilities related to neuropsychiatric conditions in the roughly half of suicide deaths with no evidence of prior nonfatal suicidal thoughts or behaviors (SD-N), a group that has not previously been accessible for study? Findings: These suicide deaths with no prior nonfatal suicidality showed significantly attenuated underlying polygenic liabilities associated with mental health traditionally thought to be core features of suicide mortality risk, and justifies additional studies of underlying risks associated with non-psychiatric conditions and behaviors. Meaning: These differences in underlying liabilities between suicide deaths with and without prior suicidality suggest departure from the traditional mental health risks that have been the focus of suicide risk discovery, and impel new directions for future research and prevention efforts.
- Open Access
- 17 April 2025
- Published by Center for Open Science in PsyArXiv
Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group
Suicidality phenotypes, consisting of suicidal ideation (SI), suicide attempt (SA), and suicide death (SD), are all heritable but present unique challenges in genome-wide association studies (GWAS) due to their individual complexity, overlap with each other and with related self-harm phenotypes, and varying associations with psychiatric disorders. GWAS have uncovered several loci associated with suicidality phenotypes by meta-analyzing data from multiple cohorts. However, combining datasets from many research groups, where each group may use different study designs, phenotyping instruments, and definitions of suicidality phenotypes, presents challenges. Heterogeneity resulting from these differences can limit genetic discovery; harmonizing phenotype definitions to ensure consistency will greatly improve results. Here, we describe a standardized phenotyping protocol that draws on the expertise of a subgroup of clinicians, researchers, and experts from the Psychiatric Genomics Consortium Suicide Working Group to propose consensus definitions for SI, SA, and SD for genetic studies.
- 17 April 2025
- Published by Center for Open Science in PsyArXiv
Open AccessDefining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group
Suicidality phenotypes, consisting of suicidal ideation (SI), suicide attempt (SA), and suicide death (SD), are all heritable but present unique challenges in genome-wide association studies (GWAS) due to their individual complexity, overlap with each other and with related self-harm phenotypes, and varying associations with psychiatric disorders. GWAS have uncovered several loci associated with suicidality phenotypes by meta-analyzing data from multiple cohorts. However, combining datasets from many research groups, where each group may use different study designs, phenotyping instruments, and definitions of suicidality phenotypes, presents challenges. Heterogeneity resulting from these differences can limit genetic discovery; harmonizing phenotype definitions to ensure consistency will greatly improve results. Here, we describe a standardized phenotyping protocol that draws on the expertise of a subgroup of clinicians, researchers, and experts from the Psychiatric Genomics Consortium Suicide Working Group to propose consensus definitions for SI, SA, and SD for genetic studies.
- Open Access
Convex approaches to isolate the shared and distinct genetic structures of subphenotypes in heterogeneous complex traits
Groups of complex diseases, such as coronary heart diseases, neuropsychiatric disorders, and cancers, often display overlapping clinical symptoms and pharmacological treatments. The shared associations of genetic variants across diseases has the potential to explain their underlying biological processes, but this remains poorly understood. To address this, we model the matrix of summary statistics of trait-associated genetic variants as the sum of a low-rank component – representing shared biological processes – and a sparse component, representing unique processes and arbitrarily corrupted or contaminated components. We introduce Clorinn , an open-source Python software that uses convex optimization algorithms to recover these components by minimizing a weighted combination of the nuclear norm and of the L1 norm. Among others, Clorinn provides two significant benefits: (a) Convex optimization guarantees reproducibility of the components, and (b) The low-rank “uncor-rupted” matrix allows robust singular value decomposition (SVD) and principal component analysis (PCA), which are otherwise highly sensitive to outliers and noise in the input matrix. In extensive simulations, we observe that Clorinn outperforms state-of-the-art approaches in capturing the shared latent factors across phenotypes. We apply Clorinn to estimate 200 latent factors from GWAS summary data of 2,110 phenotypes measured in European-ancestry Pan-UK BioBank individuals ( N = 420,531) and 14 psychiatric disorders.
Open AccessConvex approaches to isolate the shared and distinct genetic structures of subphenotypes in heterogeneous complex traits
Groups of complex diseases, such as coronary heart diseases, neuropsychiatric disorders, and cancers, often display overlapping clinical symptoms and pharmacological treatments. The shared associations of genetic variants across diseases has the potential to explain their underlying biological processes, but this remains poorly understood. To address this, we model the matrix of summary statistics of trait-associated genetic variants as the sum of a low-rank component – representing shared biological processes – and a sparse component, representing unique processes and arbitrarily corrupted or contaminated components. We introduce Clorinn , an open-source Python software that uses convex optimization algorithms to recover these components by minimizing a weighted combination of the nuclear norm and of the L1 norm. Among others, Clorinn provides two significant benefits: (a) Convex optimization guarantees reproducibility of the components, and (b) The low-rank “uncor-rupted” matrix allows robust singular value decomposition (SVD) and principal component analysis (PCA), which are otherwise highly sensitive to outliers and noise in the input matrix. In extensive simulations, we observe that Clorinn outperforms state-of-the-art approaches in capturing the shared latent factors across phenotypes. We apply Clorinn to estimate 200 latent factors from GWAS summary data of 2,110 phenotypes measured in European-ancestry Pan-UK BioBank individuals ( N = 420,531) and 14 psychiatric disorders.
- Open Access
- 24 February 2025
- Published by Elsevier in Psychiatry Research
- Vol. 347, 116391
Absence of nonfatal suicidal behavior preceding suicide death reveals differences in clinical risks
- 24 February 2025
- Published by Elsevier in Psychiatry Research
- Vol. 347, 116391
Open AccessAbsence of nonfatal suicidal behavior preceding suicide death reveals differences in clinical risks
- Open Access
- 20 February 2025
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 1-9
Distinguishing clinical and genetic risk factors for suicidal ideation and behavior in a diverse hospital population
Suicidal ideation (SI) and behavior (SB) are major public health concerns, but risk factors for their development and progression are poorly understood. We used ICD codes and a natural language processing algorithm to identify individuals in a hospital biobank with SI-only, SB, and controls without either. We compared the profiles of SB and SI-only patients to controls, and each other, using phenome-wide association studies (PheWAS) and polygenic risk scores (PRS). PheWAS identified many risk factors for SB and SI-only, plus specific psychiatric disorders which may be involved in progression from SI-only to SB. PRS for suicide attempt were only associated with SB, and even after accounting for psychiatric disorder PRS. SI PRS were only associated with SI-only, although not after accounting for psychiatric disorder PRS. These findings advance understanding of distinct genetic and clinical risk factors for SB and SI-only, which will aid in early detection and intervention efforts.
- 20 February 2025
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 1-9
Open AccessDistinguishing clinical and genetic risk factors for suicidal ideation and behavior in a diverse hospital population
Suicidal ideation (SI) and behavior (SB) are major public health concerns, but risk factors for their development and progression are poorly understood. We used ICD codes and a natural language processing algorithm to identify individuals in a hospital biobank with SI-only, SB, and controls without either. We compared the profiles of SB and SI-only patients to controls, and each other, using phenome-wide association studies (PheWAS) and polygenic risk scores (PRS). PheWAS identified many risk factors for SB and SI-only, plus specific psychiatric disorders which may be involved in progression from SI-only to SB. PRS for suicide attempt were only associated with SB, and even after accounting for psychiatric disorder PRS. SI PRS were only associated with SI-only, although not after accounting for psychiatric disorder PRS. These findings advance understanding of distinct genetic and clinical risk factors for SB and SI-only, which will aid in early detection and intervention efforts.